ADRA1D and neoplasm: Some data show that inhibition of the ADRA1D, MAPK and PI3K-Akt pathway leads to increased death in myoblast cells [73], suggesting a contribution of ADRA1D to tumor cell survival; however, we could not find previous data about its role in GBM.